Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-01-22 @ 5:58 PM
Study NCT ID:
NCT00144066
Status:
COMPLETED
Last Update Posted:
2005-09-02
First Post:
2005-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Sponsor:
West Japan Thoracic Oncology Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WJTOG0203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None